-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2012 to Q2 2024.
- Lifecore Biomedical, Inc. \De\ Deferred Tax Assets, Gross for the quarter ending May 26, 2024 was $65.9M, a 0.68% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)